Draft:Stanley T. Crooke

  • Comment: Many of the sources did not mentioned the subject at all, and those that did are either published by his institutions, lacks significant coverage, or primarily based on his own publications for sources. Multiple significant coverage are required to show that the subject passes WP:NBIO. Tutwakhamoe (talk) 00:11, 19 July 2023 (UTC)
  • Comment: Awards section is unsourced! Tails Wx 15:54, 7 March 2023 (UTC)
  • Comment: All cited sources are either written by the subject or have a close connection with the subject. 97198 (talk) 01:30, 10 November 2022 (UTC)

Stanley T Crooke
BornMarch 28, 1945
EducationMD - Baylor College of Medicine, Houston, TX, 1974

PhD Pharmacology - Baylor College of Medicine, Houston, TX, 1971

BS Pharmacy - Butler University, Indianapolis, IN, 1966

Stanley T. Crooke is an American pharmacologist and the founding CEO of Ionis Pharmaceuticals, an RNA-targeted therapeutics company. In 1989, he opened Isis Pharmaceuticals, now known as Ionis, which would go on to pioneer a drug discovery platform, antisense oligonucleotides[1]. Over the years, Ionis has developed several drugs including Spinraza[2], which is designed to treat spinal muscular atrophy (SMA). In 2020, Crooke founded the N-Lorem foundation, a non-profit designed to take advantage of the technology discovered at Ionis to provide experimental treatment to patients with extremely rare genetic disorders.

  1. ^ Herper, Matthew. "After 24 Years Of Struggle, Has Stan Crooke Finally Birthed An Age Of Antisense?". Forbes. Retrieved 2024-06-04.
  2. ^ "Stanley Crooke on finally making sense out of antisense". Chemical & Engineering News. Retrieved 2024-06-03.